Fosdevirine

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameFosdevirine
Drug Alias NameFosdevirinum磷迪韦林FosdevirinaGSK2248761AIDX-12899 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHerpesviridae InfectionsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcViiv Healthcare
Active IndicationsN/A
Inactive IndicationsHerpesviridae InfectionsHIV Infections

Other Information

ATC CodeN/A
Related LinksKEGG